LogoPressRelease.jpg
Helix Specialty Diagnostics Partners with Genomic LTC DX to Provide COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD Platform
26 janv. 2021 08h30 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm Receives CE-IVD Mark for Its Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19
21 janv. 2021 16h05 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Financial Results
07 janv. 2021 16h02 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
New Data Published in Gastroenterology Demonstrate the Power of Fluidigm’s Imaging Mass Cytometry on the Hyperion Imaging System to Identify Novel Targets for Pancreatic Cancer Therapy
05 janv. 2021 08h30 HE | Fluidigm Corporation
Study Highlighting IMC Application in Both Protein and RNA Detection Conducted by Researchers at Fluidigm Center of Excellence for Imaging Mass Cytometry at Georgetown Lombardi Comprehensive Cancer...
LogoPressRelease.jpg
Dr. Ana K. Stankovic, MD, PhD, Appointed to Fluidigm Board of Directors
15 déc. 2020 16h05 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Key Regulatory Body in India Grants Commercial License for Fluidigm Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay
24 nov. 2020 08h30 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
20 nov. 2020 21h54 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Study Utilizing Imaging Mass Cytometry Details Changes in Lung Tissue Architecture at the Single-Cell Level in Patients with COVID-19
19 nov. 2020 08h30 HE | Fluidigm Corporation
Weill Cornell Medicine Researchers Utilize Fluidigm Hyperion Imaging System to Identify a Phenotype of Immune Cell Activity Distinct from Other Lung Infections A Framework for Data-Driven Spatial...
LogoPressRelease.jpg
Fluidigm COVID-19 Community Connect Program Builds a Network of Testing Partners to Increase Access of Saliva-Based SARS-CoV-2 Testing for Communities
17 nov. 2020 08h30 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm to Present at Upcoming Health Care Investor Conference
10 nov. 2020 08h30 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...